Exelixis, Inc. (NASDAQ:EXEL) dropped by 3.05% and closed at $11.12 whereas overall traded volume stood at 1.12 million shares for the day. The current market price is 5.21% more than its last 50 days simple moving average. The share price is likely to move by 1.78 times against 1 point change in market index. Amylin [...]

Curis, Inc. (NASDAQ:CRIS) reported the fall of 6.15% to close at $3.05 with overall traded volume of 1.76 million shares in the last trading day. The current market price is 5.63% more than its last 50 days simple moving average. The relative strength index stands at 54.92 times till its last trading session. Biodel Inc [...]

Icagen, Inc. (NASDAQ:ICGN) is a biopharmaceutical company focused on the discovery, development and commercialization of orally-administered small molecule drugs that modulate ion channel targets.  It move up by 12.54% to close at $3.41 with overall traded volume of 1.47 million shares in the last trading day as compare to its average volume stood at 534.75k [...]

Celgene Corporation (NASDAQ:CELG) is an integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases. It reported the gain of 1.38% and closed at $52.24 whereas overall traded volume stood at 6.10 million shares for the day. The company stands in profit with the [...]

Icagen, Inc. (NASDAQ:ICGN) move up by 12.54% to close at $3.41 with overall traded volume of 1.47 million shares in the last trading day as compare to its average volume stood at 534.75k shares. The RSI value of 72.43 times depicts that the current shares price is highly overbought level. Angiotech Pharmaceuticals, Inc. (USA) (NASDAQ:ANPI) [...]

Zalicus, Inc. (NASDAQ:ZLCS) Incorporated is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. It surged by 11.67% and closed at $2.01 with overall traded volume of 5.03 million shares in the last trading session. Its price to earnings ratio arrives at 6.93 times till its [...]

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors (GPCRs).It gained by 0.58% and closed at $1.72 whereas overall traded volume stood at 3.41 million shares for the day. The current market price is 11.31% more than its last 50 days simple [...]

MannKind Corporation (NASDAQ: MNKD) is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. It witnessed the correction of 4.69% and closed at $8.12 whereas overall traded volume stood at 4.42 million shares for the day. The share price is at its overbought level [...]

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of hematologic and solid tumor cancers. It reported the gain of 25.64% to close at $0.49 with overall traded volume of 14.28 million shares in the last trading day. The company maintains strong [...]

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors (GPCRs) It surged by 7.14% and closed at $1.65 whereas overall traded volume stood at 13.73 million shares for the day. The value of 62.13 times depicts shows that the relative strength [...]